Investing
Top 10 Analyst Upgrades and Downgrades (ALU, BSX, EAT, CLX, GT, KMB, SBUX, TEVA, UNH, WU)
Published:
Last Updated:
These are this Tuesday’s top 10 analyst upgrades, downgrades, and initiations seen in Wall Street research calls during the pre-market hours. It is more skewed to downgrades, something we have not seen routinely in some time.
Alcatel-Lucent (NYSE: ALU) Cut to Hold from Buy at RBS.
Boston Scientific Corporation (NYSE: BSX) Cut to Sector Perform at RBC; Cut to Sell at Goldman Sachs.
Brinker International (NYSE: EAT) Cut to Underweight at Piper Jaffray.
Clorox Corporation (NYSE: CLX) Raised to Overweight at Barclays.
Goodyear Tire & Rubber Co. (NYSE: GT) Started as Underweight at Morgan Stanley.
Kimberly-Clark Corporation (NYSE: KMB) Maintained Sell but added to Conviction Sell List at Goldman Sachs.
Starbucks Corp. (NASDAQ: SBUX) Raised to Buy at UBS.
Teva Pharmaceutical Industries Limited (NASDAQ: TEVA) Removed from Conviction Buy List at Goldman Sachs, but maintained Buy.
UnitedHealth Group (NYSE: UNH) Removed from Conviction Buy List at Goldman Sachs, but maintained Buy.
Western Union (NYSE: WU) Cut to Market Perform at William Blair.
You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.
JON C. OGG
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
